Progressive Care Inc (fka RXMD)

[Jimmy Quick]

THIS IS A MUCH CLEARER PICTURE
Must show the entire PIE not just a piece of the PIE.

THERE ARE ONLY GOOD MONTHS
For instance check out increase in revenue last year.

Then check out increase in revenue from the last 2 years.


LET'S TALK ABOUT INCOME
Shall We . . .
Income For The Entire Year Of 2017 Coming In At $49,251 Is Still Something To Toot Our Horns About Eventhough Income For Fiscal Year 2016 Was $209,319 Especially when you consider the improvement from 2015 and 2014,
The Net Loss For Fiscal Year 2015 Was $(1,219,000)
And Net Loss for Fiscal Year 2014 Was (1,009,000)

Now lets analyze where some of expenses affecting additional income has been used for. See table below. Obviously it is for development and expansion initiatives. Growing, Growing, Growing. Everything says they are using money to GROW.


Also management has restructured Key Pharmacist agreement, which could result in the following increases to Net Income for 2018 and beyond.

And The Available Cash Is Half As Much !!!
End Of 2016 = $816K ... End Of 2017 = $419K

Oh, but when recorded with Accounts Receivable
December 31, 2016 = $1,683,000 and December 31, 2017 = $1,689,000
An increase of $6K and liabilities also decreased by $95K, for a net positive change of $101K.

EVERYTHING IS MOVING FORWARDS AND LOOKING GREAT !!!

MORE JUICY INFORMATION

RXMD Knows That They Will Never Be Profitable Or Have Any Sustainable Positive Income. So The Only Thing That They Can Do Is To Play The Never Ending Game Of "Always Taking Your Eye Off The Ball", And Then Substituting The Facts Of Never Obtaining Any Projected Goals, With More Story-Lines .

RXMD has been profitable for the last 2 years, while completing expansion initiatives and obtaining all of their projected goals.

Like Adding A "Silly Little Annex Location" In Order To Substitute For The Lack Of Expansion And Growth Used When Pandering To Investors In The Past, As Opposed To Any Real Growth. Only To Now Be Whittled Down To An "Annex Location", And Then Used As An Excuse To Justify For The Lack Of Income And Profits Going Forward ... LOL ... SO TRUE !!!

The little annex is 5000 square feet, and already bringing in over 1 million in revenue, which RXMD will turn into over at least 5 million guaranteed by mid 2019.


================================

DILUTION
According To OTC The OS For RXMD Has
Increased From 352M To 418M Since Jan !

That's 66M Shrs In Just 3 Months !!!

40 million were issued to management and CV has already sold the shares issued that increased the amount from 352M to 372M. The additional 4 million your showing have been issued to CV for acquisition, with another 10 million to follow. Everyone forgets that the acquisition either impacts cash on hand or it impacts shares outstanding. Both affect the bottom line. I seem to remember a reference above about cash on hand, which is absolutely awesome condition for an OTC company.

================================

UNIT REVS ARE GOING ** B A C K W A R D S **

COMPARE THESE MONTHS
March 2016 = $83 Per Rx-Unit
March 2017 = $94 Per Rx-Unit
March 2018 = $83 Per Rx-Unit

COMPARE THE Q AVERAGE
Q-1 2016 = $77.60 Per Rx-Unit
Q-1 2017 = $91.79 Per Rx-Unit
Q-1 2018 = $78.10 Per Rx-Unit

How Did The Rx-Unit-$ Go Backwards ?

It’s simple. Scripts include 340B sales and the $1.9 million revenues reported do not include 340B revenues. As 340B scripts continue to increase, which we obviously know they are, the revenue per script will likely continue to decrease. Simple Math.

SHORT TERM PRICE TARGET $.35